Monolith
Indica cannabis strain — reported effects, flavors, THC/CBD data, terpenes, and lineage.
Strain facts
| Type | Indica |
|---|---|
| Reported effects | Relaxed, Sleepy, Tingly, Euphoric, Focused |
| Flavor & aroma | Earthy, Pine |
Reported effects
- Relaxed
- Sleepy
- Tingly
- Euphoric
- Focused
Effects are self-reported in the reference dataset and vary by person, dose, tolerance, and product. They are not a prediction of how Monolith will affect you.
Flavor, aroma & terpenes
- Earthy
- Pine
These flavor notes point to terpenes such as Myrcene, Pinene, Humulene, Terpinolene — read the guides to learn what each one smells like and why it matters.
Conditions people report it for
- Insomnia
- Lack of Appetite
- Pain
- Stress
- Depression
These are anecdotal reports from the dataset — not medical evidence and not a recommendation. Cannabis research is still developing, and no strain treats or cures any condition. If you are considering cannabis for a health condition, talk to a qualified clinician first.
Frequently asked questions
- Is Monolith indica or sativa?
- Monolith is classified as a indica strain in the reference dataset. Classifications describe the strain's reported lineage and typical profile, not a guarantee of how any individual will respond.
- What are the reported effects of Monolith?
- Users in the reference dataset most often report relaxed, sleepy, tingly, euphoric, focused from Monolith. Reported effects vary by person, dose, and product.
- What does Monolith taste and smell like?
- Monolith is commonly described as tasting and smelling of earthy, pine.
- What conditions do people report using Monolith for?
- The dataset lists insomnia, lack of appetite, pain, stress among conditions users report Monolith for. This is anecdotal, not medical evidence — talk to a clinician before using cannabis for any condition.
- Where can I learn the rules for medical cannabis in my state?
- Cannabis laws differ by state. See the Caregivers Grove state guides for official, state-sourced program information.